In one paragraphArticle in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Merve GurakarDivision of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross Research Building, Suite 918, Baltimore, MD 21205, USA.
Ozge Sila OzgurDepartment of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Nazli Begum OzturkDivision of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.ORCID 0000-0002-8595-1838 Mehmet M BilgiliDivision of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross Research Building, Suite 918, Baltimore, MD 21205, USA.ORCID 0009-0000-3680-0972 Ximena ParragaDivision of Gastroenterology and Hepatology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.ORCID 0009-0000-5780-8156 Marwan AlsaqaDivision of Gastroenterology and Hepatology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.ORCID 0009-0003-1211-411X Eyad AbdulrazzakDepartment of Internal Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.ORCID 0009-0001-1489-2850 Shanmukh Sai Pavan LingamsettyDivision of Gastroenterology and Hepatology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.ORCID 0000-0001-9560-8390 Alan BonderDivision of Gastroenterology and Hepatology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.ORCID 0000-0001-6821-0416 Ahmet GurakarDivision of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross Research Building, Suite 918, Baltimore, MD 21205, USA.ORCID 0000-0002-2221-9148 Behnam SaberiDivision of Gastroenterology and Hepatology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.ORCID 0000-0002-7157-5827 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cholangiocarcinomahepatocellular carcinomaliver transplantationliving-donor liver transplantation
Identifiers
PMID41156176
PMCPMC12565021
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390